• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外泌体 miRNA 标志物用于胰腺导管腺癌的检测。

An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma.

机构信息

Micro and Nanotechnology in Medicine, College of Engineering and Computer Science, Boca Raton, FL 33431, USA.

Department of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA.

出版信息

Biosensors (Basel). 2022 Oct 6;12(10):831. doi: 10.3390/bios12100831.

DOI:10.3390/bios12100831
PMID:36290970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9599289/
Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains a difficult tumor to diagnose and treat. To date, PDAC lacks routine screening with no markers available for early detection. Exosomes are 40-150 nm-sized extracellular vesicles that contain DNA, RNA, and proteins. These exosomes are released by all cell types into circulation and thus can be harvested from patient body fluids, thereby facilitating a non-invasive method for PDAC detection. A bioinformatics analysis was conducted utilizing publicly available miRNA pancreatic cancer expression and genome databases. Through this analysis, we identified 18 miRNA with strong potential for PDAC detection. From this analysis, 10 (MIR31, MIR93, MIR133A1, MIR210, MIR330, MIR339, MIR425, MIR429, MIR1208, and MIR3620) were chosen due to high copy number variation as well as their potential to differentiate patients with chronic pancreatitis, neoplasms, and PDAC. These 10 were examined for their mature miRNA expression patterns, giving rise to 18 mature miRs for further analysis. Exosomal RNA from cell culture media was analyzed via RTqPCR and seven mature miRs exhibited statistical significance (miR-31-5p, miR-31-3p, miR-210-3p, miR-339-5p, miR-425-5p, miR-425-3p, and miR-429). These identified biomarkers can potentially be used for early detection of PDAC.

摘要

胰腺导管腺癌(PDAC)仍然是一种难以诊断和治疗的肿瘤。迄今为止,PDAC 缺乏常规筛查,也没有用于早期检测的标志物。外泌体是 40-150nm 大小的细胞外囊泡,其中包含 DNA、RNA 和蛋白质。这些外泌体由所有细胞类型释放到循环中,因此可以从患者的体液中采集,从而为 PDAC 的检测提供一种非侵入性的方法。利用公开的 miRNA 胰腺癌细胞表达和基因组数据库进行了生物信息学分析。通过这项分析,我们确定了 18 种具有很强 PDAC 检测潜力的 miRNA。在此分析中,选择了 10 个 miRNA(MIR31、MIR93、MIR133A1、MIR210、MIR330、MIR339、MIR425、MIR429、MIR1208 和 MIR3620),因为它们的拷贝数变异较高,并且有可能区分慢性胰腺炎、肿瘤和 PDAC 患者。对这 10 个 miRNA 的成熟 miRNA 表达模式进行了检测,得到了 18 个成熟 miRNA 进行进一步分析。通过 RTqPCR 分析细胞培养介质中的外泌体 RNA,有 7 个成熟 miRNA 表现出统计学意义(miR-31-5p、miR-31-3p、miR-210-3p、miR-339-5p、miR-425-5p、miR-425-3p 和 miR-429)。这些鉴定出的生物标志物可能可用于 PDAC 的早期检测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db44/9599289/743bd4b724cb/biosensors-12-00831-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db44/9599289/41b93584c05d/biosensors-12-00831-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db44/9599289/75022a07e69f/biosensors-12-00831-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db44/9599289/482c4672634a/biosensors-12-00831-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db44/9599289/743bd4b724cb/biosensors-12-00831-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db44/9599289/41b93584c05d/biosensors-12-00831-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db44/9599289/75022a07e69f/biosensors-12-00831-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db44/9599289/482c4672634a/biosensors-12-00831-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db44/9599289/743bd4b724cb/biosensors-12-00831-g004.jpg

相似文献

1
An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma.外泌体 miRNA 标志物用于胰腺导管腺癌的检测。
Biosensors (Basel). 2022 Oct 6;12(10):831. doi: 10.3390/bios12100831.
2
Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study.外泌体 miRNA 生物标志物panel 用于患者血浆中胰腺导管腺癌的检测:一项初步研究。
Int J Mol Sci. 2023 Mar 7;24(6):5081. doi: 10.3390/ijms24065081.
3
Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.血液中小细胞外囊泡衍生的 microRNA 可区分胰腺导管腺癌与慢性胰腺炎。
Clin Transl Med. 2021 Sep;11(9):e520. doi: 10.1002/ctm2.520.
4
Exosomal miR-199a-3p Secreted From Cancer-Associated Adipocytes Promotes Pancreatic Cancer Progression.肿瘤相关脂肪细胞分泌的外泌体 miR-199a-3p 促进胰腺癌进展。
Cancer Med. 2024 Oct;13(20):e70265. doi: 10.1002/cam4.70265.
5
Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma.胰腺液外泌体 microRNAs 作为胰腺导管腺癌检测的生物标志物。
Ann Surg Oncol. 2019 Jul;26(7):2104-2111. doi: 10.1245/s10434-019-07269-z. Epub 2019 Feb 28.
6
Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma.血清外泌体miRNA-1226作为胰腺导管腺癌的潜在生物标志物
Onco Targets Ther. 2021 Feb 26;14:1441-1451. doi: 10.2147/OTT.S296816. eCollection 2021.
7
Macrophage-derived exosomal microRNAs promote metastasis in pancreatic ductal adenocarcinoma.巨噬细胞衍生的外泌体 microRNAs 促进胰腺导管腺癌转移。
Int Immunopharmacol. 2024 Mar 10;129:111590. doi: 10.1016/j.intimp.2024.111590. Epub 2024 Feb 4.
8
Exosomes secreted from human umbilical cord mesenchymal stem cells promote pancreatic ductal adenocarcinoma growth by transferring miR-100-5p.人脐带间充质干细胞分泌的外泌体通过转移 miR-100-5p 促进胰腺导管腺癌生长。
Tissue Cell. 2021 Dec;73:101623. doi: 10.1016/j.tice.2021.101623. Epub 2021 Aug 14.
9
Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.巨噬细胞衍生的外泌体 microRNA-501-3p 通过 TGFBR3 介导的 TGF-β 信号通路促进胰腺导管腺癌的进展。
J Exp Clin Cancer Res. 2019 Jul 15;38(1):310. doi: 10.1186/s13046-019-1313-x.
10
Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma.血清 microRNA panel 作为胰腺导管腺癌潜在的非侵入性生物标志物。
Sci Rep. 2021 Feb 2;11(1):2824. doi: 10.1038/s41598-021-82266-5.

引用本文的文献

1
Circulating extracellular vesicles protein expression for early prediction of platinum-resistance in high-grade serous ovarian cancer.循环细胞外囊泡蛋白表达用于高级别浆液性卵巢癌铂耐药的早期预测
Oncogene. 2025 May;44(17):1197-1203. doi: 10.1038/s41388-025-03382-4. Epub 2025 Apr 10.
2
Development of liquid biopsy in detection and screening of pancreatic cancer.液体活检在胰腺癌检测与筛查中的发展
Front Oncol. 2024 Jun 3;14:1415260. doi: 10.3389/fonc.2024.1415260. eCollection 2024.
3
Emerging Horizons in the Diagnosis of Pancreatic Cancer: The Role of Circulating microRNAs as Early Detection Biomarkers for Pancreatic Ductal Adenocarcinoma.

本文引用的文献

1
MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4.微小 RNA miR-330-3p 通过靶向 RIPK4 抑制卵巢癌的进展。
Bioengineered. 2021 Dec;12(1):440-449. doi: 10.1080/21655979.2021.1871817.
2
circSFMBT1 promotes pancreatic cancer growth and metastasis via targeting miR-330-5p/PAK1 axis.环状 SFMBT1 通过靶向 miR-330-5p/PAK1 轴促进胰腺癌的生长和转移。
Cancer Gene Ther. 2021 Apr;28(3-4):234-249. doi: 10.1038/s41417-020-00215-2. Epub 2020 Aug 28.
3
Updated risk factors to inform early pancreatic cancer screening and identify high risk patients.
胰腺癌诊断的新视野:循环微小RNA作为胰腺导管腺癌早期检测生物标志物的作用
Cureus. 2024 Jan 26;16(1):e53023. doi: 10.7759/cureus.53023. eCollection 2024 Jan.
4
Emerging Therapeutic Options in Pancreatic Cancer Management.胰腺癌治疗的新选择。
Int J Mol Sci. 2024 Feb 5;25(3):1929. doi: 10.3390/ijms25031929.
5
miRNAs in pancreatic cancer progression and metastasis.miRNAs 在胰腺癌进展和转移中的作用。
Clin Exp Metastasis. 2024 Jun;41(3):163-186. doi: 10.1007/s10585-023-10256-0. Epub 2024 Jan 19.
6
Development of a Microfluidic Device for Exosome Isolation in Point-of-Care Settings.开发一种用于即时检测环境中细胞外囊泡分离的微流控装置。
Sensors (Basel). 2023 Oct 7;23(19):8292. doi: 10.3390/s23198292.
7
Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study.外泌体 miRNA 生物标志物panel 用于患者血浆中胰腺导管腺癌的检测:一项初步研究。
Int J Mol Sci. 2023 Mar 7;24(6):5081. doi: 10.3390/ijms24065081.
更新风险因素以进行早期胰腺癌筛查并识别高危患者。
Cancer Lett. 2020 Aug 10;485:56-65. doi: 10.1016/j.canlet.2020.04.022. Epub 2020 May 8.
4
Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application.非编码 RNA 在癌症免疫中的作用:功能、调控机制及临床应用。
Mol Cancer. 2020 Mar 2;19(1):48. doi: 10.1186/s12943-020-01154-0.
5
Exosomal biomarkers for cancer diagnosis and patient monitoring.外泌体生物标志物用于癌症诊断和患者监测。
Expert Rev Mol Diagn. 2020 Apr;20(4):387-400. doi: 10.1080/14737159.2020.1731308. Epub 2020 Feb 20.
6
Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis.癌症长链非编码 RNA 普查揭示了长链非编码 RNA 在肿瘤发生中深度功能保守的证据。
Commun Biol. 2020 Feb 5;3(1):56. doi: 10.1038/s42003-019-0741-7.
7
The Role of Non-coding RNAs in Oncology.非编码 RNA 在肿瘤学中的作用。
Cell. 2019 Nov 14;179(5):1033-1055. doi: 10.1016/j.cell.2019.10.017.
8
The Emerging Role of Major Regulatory RNAs in Cancer Control.主要调控RNA在癌症控制中的新兴作用
Front Oncol. 2019 Sep 24;9:920. doi: 10.3389/fonc.2019.00920. eCollection 2019.
9
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas.胆道和胰腺肿瘤前病变和肿瘤之间的共同特征。
World J Gastroenterol. 2019 Aug 21;25(31):4343-4359. doi: 10.3748/wjg.v25.i31.4343.
10
Emerging roles of lncRNA in cancer and therapeutic opportunities.长链非编码RNA在癌症中的新作用及治疗机会
Am J Cancer Res. 2019 Jul 1;9(7):1354-1366. eCollection 2019.